Learn how the Veristat team quickly mobilized to help a sponsor get their clinical trial databased designed and launched in two weeks in order to achieve first-patient-in for a COVID-19 vaccine.
Case Study
When the WHO declared the Ebola Outbreak of 2014 in Africa a Global Health Emergency, Veristat was contacted to quickly set up clinical trial sites. Learn how we overcame the urgency and challenges of supporting a vaccine program for a global infectious disease outbreak.
Case Study
Patient recruitment delays are common challenges in clinical trials that can lead to costly delays. In fact, nearly 80 percent of patient recruitment timelines in clinical trials are not met and over 50 percent of the patients are not enrolled within the planned timeframes.
Case Study
A biopharmaceutical firm specializing in rare and ultra-rare disease research started working with Veristat over 7 years ago.
Case Study
Imagine you are getting ready to launch the third drug cohort of your early phase clinical trial for a pancreatic cancer vaccine study and your in-house lead CRA overseeing your sites in Europe retires. This happened to our client, who brought on Veristat to transition and seamlessly continue monitoring for the sites in this cohort.
Case Study
A clinical-stage biopharmaceutical company came to Veristat with a complex statistical methodology for running a phase II adaptive design trial with the goal of expediting a go/no-go decision for a specific patient population.
Case Study
We are more than just your typical boutique "CRO" that caters to growing firms. Meet us and consider why you should speak with Veristat for the design and implementation of your clinical trials and regulatory submissions.
Case Study
A mid-size pharmaceutical company and its development partner, a small biotechnology company engaged Veristat to complete the medical writing for their product’s Marketing Authorization Application (MAA), New Drug Application (NDA), and New Drug Submission (NDS).
Case Study
